| 1 | CLDN9
|
| Claudin‑9 is a novel prognostic biomarker for endometrial cancer
|
| Endo Y, Sugimoto K, Kobayashi M, Kobayashi Y, Kojima M, Furukawa S, Soeda S, Watanabe T, Higashi AY, Higashi T, Hashimoto Y, Fujimori K, Chiba H.
|
| Int J Oncol. Nov;61(5):135. doi: 10.3892/ijo.2022.5425. Epub 2022 Sep 21. 2022
|
| 2 | CLDN9, DFNB116
|
| Variants of human CLDN9 cause mild to profound hearing loss.
|
| Ramzan M, Philippe C, Belyantseva IA, Nakano Y, Fenollar-Ferrer C, Tona R, Yousaf R, Basheer R, Imtiaz A, Faridi R, Munir Z, Idrees H, Salman M, Nambot S, Vitobello A, Kartti S, Zarrik O, Witmer PD, Sobreria N, Ibrahimi A, Banfi B, Moutton S, Friedman TB, Naz S.
|
| Hum Mutat. Oct;42(10):1321-1335. doi: 10.1002/humu.24260. Epub 2021 Aug 1. 2021
|
| 3 | CLDN9
|
| Claudin-9 constitutes tight junctions of folliculo-stellate cells in the anterior pituitary gland.
|
| Higashi AY, Higashi T, Furuse K, Ozeki K, Furuse M, Chiba H.
|
| Sci Rep. Nov 4;11(1):21642. doi: 10.1038/s41598-021-01004-z. 2021
|
| 4 | CLDN9, DFNB116
|
| A truncating CLDN9 variant is associated with autosomal recessive nonsyndromic hearing loss
|
| Sineni CJ, Yildirim-Baylan M, Guo S, Camarena V, Wang G, Tokgoz-Yilmaz S, Duman D, Bademci G, Tekin M.
|
| Hum Genet. Oct;138(10):1071-1075. doi: 10.1007/s00439-019-02037-1. Epub 2019 Jun 7. 2019
|
| 5 | CLDN9, NDRG1
|
| NDRG1 is important to maintain the integrity of airway epithelial barrier through claudin-9 expression
|
| Gon Y, Maruoka S, Kishi H, Kozu Y, Kazumichi K, Nomura Y, Takeshita I, Oshima T, Hashimoto S.
|
| Cell Biol Int. Jul;41(7):716-725. doi: 10.1002/cbin.10741. Epub 2017 Mar 10. 2017
|
| 6 | CLDN9
|
| A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis
|
| Sharma RK, Chheda ZS, Das Purkayastha BP, Gomez-Gutierrez JG, Jala VR, Haribabu B.
|
| Clin Exp Metastasis. Mar;33(3):263-75. doi: 10.1007/s10585-015-9776-4. Epub 2015 Dec 15. 2016
|
| 7 | CLDN9
|
| Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytoma
|
| Hong L, Wu Y, Feng J, Yu S, Li C, Wu Y, Li Z, Cao L, Wang F, Zhang Y.
|
| Hum Pathol. Dec;45(12):2423-9. doi: 10.1016/j.humpath.2014.08.006. Epub 2014 Sep 2. 2014
|
| 8 | CLDN9
|
| A claudin-9-based ion permeability barrier is essential for hearing.
|
| Nakano Y, Kim SH, Kim HM, Sanneman JD, Zhang Y, Smith RJ, Marcus DC, Wangemann P, Nessler RA, Bánfi B.
|
| PLoS Genet 5(8):e1000610. Epub 2009 Aug 21.PMID: 19696885 2009
|
| 9 | CLDN1, CLDN6, CLDN9
|
| The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
|
| Meertens L, Bertaux C, Cukierman L, Cormier E, Lavillette D, Cosset FL, Dragic T.
|
| J Virol 82(7):3555-60. Epub 2008 Jan 30.PMID: 18234789 2008
|
| 10 | CLDN6, CLDN9
|
| Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
|
| Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J, Song X, Ding M, Deng H.
|
| J Virol 81(22):12465-71. Epub 2007 Sep 5.PMID: 17804490 2007
|
| 11 | CLDN1, CLDN12, CLDN14, CLDN18, CLDN2, CLDN3, CLDN6, CLDN8, CLDN9
|
| Expression patterns of claudins, tight junction adhesion molecules, in the inner ear.
|
| Kitajiri SI, Furuse M, Morita K, Saishin-Kiuchi Y, Kido H, Ito J, Tsukita S.
|
| Hear Res 187(1-2):25-34.PMID: 14698084 2004
|
| 12 | CLDN1, CLDN10, CLDN11, CLDN12, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN21, CLDN22, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9
|
| Claudins create charge-selective channels in the paracellular pathway between epithelial cells.
|
| Colegio OR, Van Itallie CM, McCrea HJ, Rahner C, Anderson JM.
|
| Am J Physiol Cell Physiol 283(1):C142-7. 2002
|
| 13 | CLDN1, CLDN2, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9
|
| Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands.
|
| Morita K, Furuse M, Fujimoto K, Tsukita S.
|
| Proc Natl Acad Sci U S A 96(2):511-6. 1999
|